Consistently, we demonstrated that patients with MAFLD had significantly higher BMI, WC, ALT, AST, γ-GT, TG, FINS, HOMA-IR, and CRP levels as well as increased proportions of obesity, hypertension, hyperlipidemia, IR, hepatic steatosis, and fibrosis compared with those without MAFLD in both genders. This evidence concerns the gene GPT and hyperlipidemia.